As the world races to find a vaccine for COVID-19, our colleague Dr Cem Gun, an Emergency Medicine Physician at Acıbadem University Atakent Hospital, has bravely volunteered for the country’s first clinical trial. On 9 October, he was administered the first dose of a COVID-19 vaccine developed in China and approved for trial by the Health Institutes of Turkey, at a high-key milestone event.
On why he volunteered for this trial, Dr Cem Gun said, “As a healthcare worker, I fall into the high-risk group for COVID-19 infection. I decided to be vaccinated not only to protect myself but also my patients and loved ones. I made this decision with peace of mind as it is a controlled trial; it is currently in Phase 3, making it a tested and safe vaccine.”
The vaccine will be administered in two doses, and volunteers will be monitored on its effectiveness over a year.
The World Bank has approved US$12 billion in financing to help developing countries buy and distribute COVID-19 vaccines, tests and treatments, aiming to support the vaccination of up to 1 billion people.
Related Stories
Gleneagles JPMC Strengthens Regional Cardiac Collaboration
Gleneagles JPMC joined leading cardiac professionals at the 30th ASEAN Federation of Cardiology Congress, supporting knowledge exchange and regional collaboration to advance cardiovascular care across ASEAN.
Gleneagles Hong Kong Advances Healthier Ageing Through Innovation
Gleneagles Hospital Hong Kong shared clinical insights and industry perspectives at Ageing Well Hong Kong 2026, highlighting how innovation, prevention and collaboration can support healthier ageing and improved quality of life.
Turning Clinical Insights into Better Patient Outcomes
.jpg?sfvrsn=745604e1_1)
Gleneagles Hong Kong Leads the Way in Advancing Liver Cancer Care
Gleneagles Hong Kong and HKUMed are advancing liver cancer care through collaboration and innovation under IHH Healthcare’s leadership.
55fda2dc551e4ff68748a1aabe8694a6.jpg?sfvrsn=a1e3ed8c_1)
Parkway East Hospital Supports Healthy Ageing with Its New Live Well Centre and Sleep Laboratory
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
